BHR Pharma, LLC

Quick facts

Marketed products

• Progesterone oral capsule

Phase 3 pipeline

• Lipid emulsion without progesterone
  A lipid emulsion formulation that delivers lipophilic compounds without progesterone as an active pharmaceutical ingredient.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BHR Pharma, LLC portfolio CI brief
• BHR Pharma, LLC pipeline updates RSS